Periodontitis Treatment Lowers Systemic Inflammation in type 2 diabetes.

Summarised from:

Treatment of periodontitis reduces systemic inflammation in type 2 diabetes.
(Journal of Clinical Periodontology; doi: 10.1111/jcpe.13274)

Authors:

Philip M. Preshaw, John J. Taylor, Katrin M. Jaedicke, Marko De Jager, Jan Willem Bikker, Wieke Selten, Susan M. Bissett, Kerry M. Whall, Rachel van de Merwe, Aisha Areibi, Paiboon Jitprasertwong, Rana Al-Shahwani, Jolanta Weaver, Roy Taylor, Rebecca R. Wassall

Summarised by:

Dr Varkha Rattu

Research Topic:

Background + Aims

  • Periodontitis, affecting 11.2% globally, causes tissue destruction, tooth loss, and reduced quality of life. Its bidirectional link with type 2 diabetes mellitus (T2DM) is well-established, with diabetes increasing periodontitis risk and periodontitis worsening glycemic control.
  • Meta-analyses show periodontitis treatment reduces HbA1c by 0.3%–0.4% and improves endothelial function. Systemic inflammation, driven by elevated pro-inflammatory mediators and oxidative stress, likely connects these conditions, though mechanisms remain unclear. Entry of periodontal bacteria into circulation and advanced glycation interactions further exacerbate inflammation in diabetes.
  • This study aimed to assess periodontal and systemic inflammation by periodontal status in individuals with and without T2DM and evaluate the effects of periodontitis treatment on these inflammatory markers in both groups.

Materials + Methods

  • This descriptive study investigated the clinical and biochemical outcomes of periodontitis treatment in individuals with and without T2DM. Adults aged 30–55 with at least 20 teeth were recruited from clinics in the UK, with exclusion criteria including pregnancy, immunosuppression, recent periodontal treatment, and inflammatory conditions.
  • Periodontal examinations assessed plaque, gingival indices, probing depths, and bleeding on probing (BOP).
  • Participants were categorised as healthy, gingivitis, or periodontitis. Those with periodontitis received oral hygiene instructions and non-surgical therapy (root surface debridement), followed by maintenance appointments at 3, 6, and 12 months.
  • Blood samples were collected at baseline and follow-up to measure HbA1c, high-sensitivity CRP (hsCRP), and inflammatory markers like IL-6, TNF-α, and MMP-8 using ELISA and multiplex assays. Gingival crevicular fluid (GCF) samples were analysed for local inflammation markers.
  • Structural equation modelling (SEM) was used to evaluate systemic and oral inflammation as latent variables. The original sample-size calculation estimated 85% power to detect an HbA1c change of 0.6 percentage points. Statistical analysis included Wilcoxon tests and SEM to explore associations between systemic and oral inflammation, comparing baseline and 12-month outcomes within and across groups. Data transformations ensured normality for biochemical variables.

Results

  • A total of 83 individuals with T2DM and 75 non-diabetic controls were included. Participants were similar in age, gender, and smoking habits, but those with diabetes had significantly higher BMI (p < .001).
  • At baseline, individuals with diabetes and periodontitis had higher HbA1c levels and systemic inflammation markers compared to non-diabetic controls. At baseline, systemic inflammation correlated moderately with oral inflammation in the diabetes group (r = .58, p = .02).
  • Non-diabetic individuals with periodontitis compared to their periodontally healthy counterparts had significantly higher hsCRP (p < .05). No significant differences in baseline serum IL-6 or TNF-α levels were observed between groups.
  • Clinical periodontal measures improved significantly following treatment in both groups. Several GCF inflammatory biomarkers also decreased, although the timing and statistical significance varied by biomarker and group.
  • Among participants with diabetes and periodontitis, median HbA1c decreased from 59 mmol/mol (7.5%) at baseline to 54 mmol/mol (7.1%) at 12 months. This change was not statistically significant (p = .08).
  • Participants with diabetes and periodontitis showed a greater reduction in systemic inflammation over 12 months than those with periodontitis without diabetes (between-group difference in change in the SEM-derived inflammation score: Δ = −0.25; p = .013). This estimate describes systemic inflammation, not an HbA1c percentage change.
  • These findings suggest a potential systemic anti-inflammatory benefit of periodontal treatment in people with diabetes. Additional analyses indicated that BMI did not explain the observed between-group difference.

Limitations

  • This observational study lacked randomisation, limiting its ability to establish causality.
  • The authors acknowledged that the study was underpowered to detect the observed HbA1c change: the original calculation assumed a larger improvement than was subsequently observed. The non-significant result therefore does not rule out a smaller glycaemic benefit.
  • Mediators were pre-selected based on existing knowledge, potentially omitting other relevant biomarkers.
  • Smoking effects on outcomes were not analysed, highlighting a need for future studies to address its role.
  • Recruitment strategies introduced potential bias, as non-diabetic controls were referred for advanced periodontitis, while individuals with diabetes were recruited from diabetes clinics.

Conclusion

  • This study explored the relationship between periodontitis and type 2 diabetes, highlighting the bidirectional links between the two conditions.
  • Individuals with diabetes exhibited higher systemic inflammation at baseline and potentially increased susceptibility to oral inflammation. Periodontal treatment significantly improved clinical parameters and reduced inflammation in both diabetic and non-diabetic individuals, with comparable treatment responses. Notably, reductions in systemic inflammation were greater in those with diabetes, suggesting potential systemic benefits of therapy in this group.
  • The findings support periodontal care for people with diabetes and suggest a potential benefit in reducing systemic inflammation. This study did not demonstrate a statistically significant improvement in HbA1c or establish broader improvements in overall health outcomes.
Read the full article Back to Research

Research  |  27.02.20

clock icon 8 mins to read

Share this page:

Copy Link

You might also like...

Events

Periodontitis-Diabetes Hub x #DiabetesChat

Hosted by #diabeteschat, join Dr Varkha Rattu and the team behind the Periodontitis-Diabetes Hub for an insightful discussion exploring the importance of managing periodontitis and diabetes.

Read more

Events

Oral Health Challenges Among People Living With Diabetes

Dr Antoniszczak will present a lecture about the oral health challenges among people living with diabetes. This lecture explores the key challenges faced by individuals living with diabetes, focusing on…

Read more

Events

Periodontitis-Diabetes Hub x #DiabetesChat

Hosted by #diabeteschat, join Dr Varkha Rattu and the team behind the Periodontitis-Diabetes Hub for an insightful discussion exploring the importance of managing periodontitis and diabetes.

Read more

Events

Oral Health Challenges Among People Living With Diabetes

Dr Antoniszczak will present a lecture about the oral health challenges among people living with diabetes. This lecture explores the key challenges faced by individuals living with diabetes, focusing on the relationship between diabetes and oral health.

Read more
icon1 services

Periodontitis is the 6th most prevalent condition globally

icon1 services

Periodontitis and diabetes are bidirectionally linked

icon1 services

Diabetic complications are increased if you have both diseases

icon1 services

Successful periodontal treatment can improve blood glucose control

icon1 services

Periodontitis is the 6th most prevalent condition globally

icon1 services

Periodontitis and diabetes are bidirectionally linked

icon1 services

Diabetic complications are increased if you have both diseases

icon1 services

Successful periodontal treatment can improve blood glucose control

Events

20.11.26

Bangalore, India

Oral Health and Diabetes

A four-day scientific programme featuring nearly 200 sessions, encompassing prestigious orations, state-of-the-art lectures, thought-provoking debates,…

Read more
VIEW ALL

Our Team

Team - The Periodontitis-Diabetes Hub

Dr Varkha Rattu

Founder & Periodontology Co-Lead

Team - The Periodontitis-Diabetes Hub

Dr Amar Puttanna

Diabetes Co-Lead

Team - The Periodontitis-Diabetes Hub

Dr Rajeev Raghavan

Diabetes Co-Lead

Team - The Periodontitis-Diabetes Hub

Professor Mark Ide

Periodontology Co-Lead

Team - The Periodontitis-Diabetes Hub

Professor Luigi Nibali

Periodontology Co-Lead

Team - The Periodontitis-Diabetes Hub

Dr Dominika Antoniszczak

Education & Support Advisor

Team - The Periodontitis-Diabetes Hub

Dr Jasmine Loke

Clinical Content Advisor

Team - The Periodontitis-Diabetes Hub

Dr Mira Shah

Patient Resource Advisor

Team - The Periodontitis-Diabetes Hub

Elaine Tilling

Outreach & Communications Lead

Team - The Periodontitis-Diabetes Hub

Dr Varkha Rattu

Periodontitis-Diabetes Hub Position: Founder & Periodontology Co-Lead

Team - The Periodontitis-Diabetes Hub

Dr Amar Puttanna

Periodontitis-Diabetes Hub Position: Diabetes Co-Lead

Team - The Periodontitis-Diabetes Hub

Dr Rajeev Raghavan

Periodontitis-Diabetes Hub Position: Diabetes Co-Lead

Team - The Periodontitis-Diabetes Hub

Professor Mark Ide

Periodontitis-Diabetes Hub Position: Periodontology Co-Lead

Team - The Periodontitis-Diabetes Hub

Professor Luigi Nibali

Periodontitis-Diabetes Hub Position: Periodontology Co-Lead

Team - The Periodontitis-Diabetes Hub

Dr Dominika Antoniszczak

Periodontitis-Diabetes Hub Position: Education and Support Advisor

Team - The Periodontitis-Diabetes Hub

Dr Jasmine Loke

Periodontitis-Diabetes Hub Position: Clinical Content Advisor

Team - The Periodontitis-Diabetes Hub

Dr Mira Shah

Periodontitis-Diabetes Hub Position: Patient Resource Advisor

Team - The Periodontitis-Diabetes Hub

Elaine Tilling

Periodontitis-Diabetes Hub Position: Outreach and Communications Lead

View All